KARI SIERANT: Open Payments
NPI 1184149940 · MORRISTOWN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,113 in 55 payments from 25 companies in 2025. Trend: 2023 $3,897 · 2024 $2,790 · 2025 $1,113
Food & beverage: $1,005Education: $109
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $154 |
| Incyte Corporation | 3 | $119 |
| ABBVIE INC. | 6 | $97 |
| Novartis Pharmaceuticals Corporation | 5 | $91 |
| GlaxoSmithKline, LLC. | 4 | $72 |
| TAIHO ONCOLOGY, INC. | 3 | $68 |
| PFIZER INC. | 3 | $68 |
| Janssen Biotech, Inc. | 3 | $59 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $46 |
| Merck Sharp & Dohme LLC | 2 | $44 |
Products named: LONSURF, ENHERTU, IBRANCE, ELAHERE, LYNPARZA, JAKAFI, JEMPERLI, DARZALEX.
Industry payments across NJ — which companies pay providers there.
